Varughese RA[au] - Search Results

Year	Number of Results
2018	1
2019	2
2021	5
2022	2

1

Cumulative Deficits Frailty Index Predicts Outcomes for Solid Organ Transplant Candidates.

Varughese RA, Theou O, Li Y, Huang X, Chowdhury N, Famure O, Selzner N, MacIver J, Mathur S, Kim SJ, Rockwood K, Singer LG. Varughese RA, et al. Transplant Direct. 2021 Feb 22;7(3):e677. doi: 10.1097/TXD.0000000000001094. eCollection 2021 Mar. Transplant Direct. 2021. PMID: 34113716 Free PMC article.

2

Exertional intolerance and dyspnea with preserved lung function: an emerging long COVID phenotype?

Lam GY, Befus AD, Damant RW, Ferrara G, Fuhr DP, Stickland MK, Varughese RA, Wong EY, Smith MP. Lam GY, et al. Among authors: varughese ra. Respir Res. 2021 Aug 6;22(1):222. doi: 10.1186/s12931-021-01814-9. Respir Res. 2021. PMID: 34362372 Free PMC article.

3

Treatment of moderate to severe respiratory COVID-19: a cost-utility analysis.

Congly SE, Varughese RA, Brown CE, Clement FM, Saxinger L. Congly SE, et al. Among authors: varughese ra. Sci Rep. 2021 Sep 7;11(1):17787. doi: 10.1038/s41598-021-97259-7. Sci Rep. 2021. PMID: 34493774 Free PMC article.

4

ANOTHER syndrome-Familial presentations of progressive lung disease leading to double lung transplantation: A case report and literature review.

Thornton CS, Puttagunta L, Helmersen D, Thakrar MV, Nagendran J, Lien D, Varughese RA. Thornton CS, et al. Among authors: varughese ra. Respirol Case Rep. 2021 Nov 5;9(12):e0872. doi: 10.1002/rcr2.872. eCollection 2021 Dec. Respirol Case Rep. 2021. PMID: 34765225 Free PMC article.

5

A Prospective Evaluation of the Diagnostic Accuracy of the Physical Examination for Pulmonary Hypertension.

Braganza M, Shaw J, Solverson K, Vis D, Janovcik J, Varughese RA, Thakrar MV, Hirani N, Helmersen D, Weatherald J. Braganza M, et al. Among authors: varughese ra. Chest. 2019 May;155(5):982-990. doi: 10.1016/j.chest.2019.01.035. Epub 2019 Feb 28. Chest. 2019. PMID: 30826305

6

COVID-19 hospitalization is associated with pulmonary/diffusion abnormalities but not post-acute sequelae of COVID-19 severity.

Lam GY, Befus D, Damant RW, Ferrara G, Fuhr DP, Laratta CR, Lau A, Stickland MK, Varughese RA, Wong EY, Smith MP. Lam GY, et al. Among authors: varughese ra. J Intern Med. 2022 May;291(5):694-697. doi: 10.1111/joim.13427. Epub 2021 Dec 16. J Intern Med. 2022. PMID: 34875129

7

Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial.

Weatherald J, Thakrar MV, Varughese RA, Kularatne M, Liu J, Harper L, Kiamanesh O, Fine N, Orlikow E, Nwaroh C, Thornton C, Swiston J, Kolkman L, Brunner NW, Helmersen D, Hirani N. Weatherald J, et al. Among authors: varughese ra. J Heart Lung Transplant. 2022 May;41(5):563-567. doi: 10.1016/j.healun.2022.01.002. Epub 2022 Jan 10. J Heart Lung Transplant. 2022. PMID: 35090807 Clinical Trial.

8

Pre-transplant factors associated with mortality after lung transplantation in cystic fibrosis: A systematic review and meta-analysis.

Koutsokera A, Varughese RA, Sykes J, Orchanian-Cheff A, Shah PS, Chaparro C, Tullis E, Singer LG, Stephenson AL. Koutsokera A, et al. Among authors: varughese ra. J Cyst Fibros. 2019 May;18(3):407-415. doi: 10.1016/j.jcf.2018.10.013. Epub 2018 Oct 25. J Cyst Fibros. 2019. PMID: 30482682 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results